Key points are not available for this paper at this time.
Background Chronic skin diseases such as psoriasis, scleroderma, and vitiligo adversely affect a patients health and well-being. The evaluation of quality of life (QoL) is a crucial part of the overall care of patients with chronic skin diseases. Identification and dealing with multidimensional aspects such as physical, social, psychological, and emotional features of these diseases are important to enhance their quality of life and to obtain a better response to treatment. Methods This is a prospective, observational, cross-sectional, questionnaire-based study to evaluate the impact of chronic skin diseases (i.e. psoriasis, vitiligo, and scleroderma) on the quality of life of patients. The primary objective of this study is to measure the effect of chronic skin diseases and their treatment on patients quality of life using the Skindex-29 questionnaire. The secondary objectives are to determine the relationship between quality of life and sociodemographic variables and the relationship between quality of life and disease variables. Patients diagnosed with psoriasis, vitiligo, and scleroderma will be recruited for the study after signing a voluntary informed consent form. A validated Skindex-29 questionnaire will be used to record the emotions, symptoms, and functioning domains of the patients. Approximately 100 patients will be recruited for the study. Data analysis will be done at the end of patient recruitment. Conclusion Dermatologists can aid their patients QoL by using the Skindex-29 questionnaire score to better understand the impact of psoriasis, vitiligo, and scleroderma. Furthermore, they can aid in estimating the disease burden as well as help direct interventions to avoid further complications.
Thakare et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: